Why This Cancer Study Is Crushing Spectrum Pharma
Spectrum Pharma shares were halved on Thursday after the firm provided an update on its midstage cancer study some updates on its late-stage programs with the FDA.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 76
A Third of Adolescents Make Risky Lifestyle Choices
A new analysis of data collected from more than 300,000 adolescents worldwide show that more than a third engage in risky behaviors that could lead to premature death.
Big Pharma Short Sellers Get Selective
The December 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Major Biotechs See Rising Short Interest
The December 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Will Microbot Medical’s Robotic Surgery System Be a Big Hit?
Microbot Medical shares made a massive gain on Tuesday after the company revealed its Liberty system, which would be the world’s first fully disposable robotic system for use in neurovascular, cardiovascular and peripheral vascular…
Why This Ovarian Cancer Drug Could Be Huge for NewLink Genetics
NewLink Genetics shares jumped on Tuesday after the company announced that it entered into an exclusive worldwide license agreement with Ellipses Pharma.
Allergan Gets FDA Approval for Migraine Treatment
The FDA has approved Allergan's treatment for migraines in adults. The drug is the first of its class to obtain FDA approval, but the new drug will compete with other recently released treatments for…
The Top Biopharma Calendar Events to Watch Going Into 2020
Here, 24/7 Wall St. has included a calendar of a few of the biggest clinical trial and FDA updates to watch for going into 2020.
Why This Duchenne Muscular Dystropy Deal Could Be Huge
Sarepta Therapeutics shares made a handy gain to start the week after it announced a licensing agreement with Roche for its investigational gene therapy for Duchenne muscular dystrophy.
Why This Schizophrenia Treatment Approval Is Such a Big Deal
Intra-Cellular Therapy shares practically doubled on Monday after the firm announced that the FDA has approved Caplyta for the treatment of schizophrenia in adults
The First Ebola Vaccine Has Been Approved in the US
NewLink Genetics and Merck shares made handy gains on Friday after it was announced that the FDA has granted approval to Ervebo, the Zaire Ebola virus vaccine V920.
Is Stealth Bio Done After Mitochondrial Myopathy Study?
Stealth Bio shares were absolutely crushed on Friday after the firm announced results from its late-stage study in patients with primary mitochondrial myopathy (PMM). Specifically, the top-line results are coming from the Phase 3…
Why One Analyst Still Sees Almost 200% Upside in Paratek Pharma, Even After Its Huge Gain
This Wedbush analyst sees close to 200% in potential upside in Paratek Pharmaceuticals beyond the massive one-day gain on Thursday.
BioShield/Anthrax Contract Sets Solid Stage for Paratek Pharmaceuticals in 2020
The U.S. Department of Health and Human Services has awarded Paratek Pharmaceuticals a pact to support development of its treatment for pulmonary anthrax.
Gene Sequencing Merger May Be the Oddest Monopoly and Antitrust Case Ever
When most investors and consumers think of antitrust issues and monopolies, they probably think of big giant multinational companies with billions of dollars in sales and assets and likely even millions of customers.